Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced its intention to continue its H share repurchase plan, adjusting the maximum repurchase amount to HKD650 million due to the rising price of its H shares. The company believes that this move will demonstrate confidence in its business outlook and create value for shareholders, while maintaining a solid financial position. The repurchase is subject to regulatory approval in China and will be conducted at the discretion of the Board, depending on market conditions.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the medical technology industry, focusing on developing and providing advanced medical devices and solutions.
YTD Price Performance: 63.08%
Average Trading Volume: 141
Technical Sentiment Signal: Sell
Current Market Cap: €717.7M
See more data about 2190 stock on TipRanks’ Stock Analysis page.